Hemophagocytic lymphohistiocytosis and Epstein-Barr virus infection in children;Syndrome d'activation macrophagique et infection à virus d'Epstein-Barr chez l'enfant

Medecine et Maladies Infectieuses

Volumn 40, Issue 1, 2010, Pages 18-26

  Darteyre, S ^a   Ludwig, C ^b   Jeziorski, E ^b   Schved, J F ^c   Rodiere M ^b  

^a Centre Hospitalier de la Polynesie Francaise CHPF   (French Polynesia)

^b HÔPITAL ARNAUD DE VILLENEUVE   (France)

^c HÔPITAL SAINT ELOI   (France)

Author keywords

EBV; Hemophagocytic lymphohistiocytosis

Indexed keywords

BIOLOGICAL MARKER; CORTICOSTEROID; CYCLOSPORIN A; METHOTREXATE; PREDNISONE; RITUXIMAB;

AGE; ARTICLE; CASE REPORT; CHILD; CLINICAL PROTOCOL; DEATH; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE SEVERITY; EPSTEIN BARR VIRUS; FAMILY HISTORY; FEMALE; FEVER; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HEPATOSPLENOMEGALY; HOSPITAL ADMISSION; HUMAN; INFANT; LIVER FAILURE; MALE; NEUROLOGIC DISEASE; POLYMERASE CHAIN REACTION; SEROLOGY; SPLENOMEGALY; VIRUS INFECTION;

ALGORITHMS; CHILD; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; INFANT; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE;

EID: 73849103903     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2009.06.004     Document Type: Article

References (25)

1. Lindemann T.L., and Greene J.S. Persistent cervical lymphadenopathy in an adolescent with Epstein-Barr induced hemophagocytic syndrome: manifestations of a rare but often fatal disease. Int J Pediatr Otorhinolaryngol. 69 7 (2005) 1011-1014
2. Janka G.E. Hemophagocytic syndromes. Blood Rev 21 5 (2007) 245-253
3. Lambotte O., and Méchaï F. Syndrome d'activation macrophagique. La Lettre de l'Infectiologue XXII 3 (2007)
4. Imashuku S., Hibi S., Ohara T., Iwai A., Sako M., Kato M., et al. Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Histiocyte Soc Blood 93 6 (1999) 1869-1874
5. Henter J.I., Samuelsson-Horne A., Aricò M., Egeler R.M., Elinder G., Filipovich A.H., et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 100 7 (2002) 2367-2373
6. Henter J.I., Horne A., Arico M., Egeler R.M., Filipovich A.H., Imashuku S., et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48 2 (2007) 124-131
7. Imashuku S. Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol 44 3 (2002) 259-272
8. Ohga S., Nomura A., Takada H., and Hara T. Immunological aspects of Epstein-Barr virus infection. Crit Rev Oncol Hematol 44 3 (2002) 203-215
9. Fisman D.N. Hemophagocytic syndromes and infection. Emerg Infect Dis 6 6 (2000) 601-608
10. Pasic S., Micic D., and Kuzmanovic M. Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis in Wiskott-Aldrich syndrome. Acta Paediatr 92 7 (2003) 859-861
11. Imashuku S., Teramura T., Tauchi H., Ishida Y., Otoh Y., Sawada M., et al. Longitudinal follow-up of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Haematologica 89 2 (2004) 183-188
12. Ueda I., Ishii E., Morimoto A., Ohga S., Sako M., and Imashuku S. Comment in: Pediatr Blood Cancer. 2006 Apr; 46 (4): 409-11. Correlation between phenotypic heterogeneity and gene mutational characteristics in familial hemophagocytic lymphohistiocytosis (FHL). Pediatr Blood Cancer 46 4 (2006) 482-488
13. Ishii E., Ueda I., Shirakawa R., Yamamoto K., Horiuchi H., Ohga S., et al. Genetic subtypes of familial hemophagocytic lymphohistiocytosis: correlations with clinical features and cytotoxic T lymphocyte/natural killer cell functions. Blood 105 9 (2005) 3442-3448
14. Dupré L., Andolfi G., Tangye S.G., Clementi R., Locatelli F., Aricò M., et al. SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells. Blood 105 11 (2005) 4383-4389
15. Arico M., Imashuku S., Clementi R., Hibi S., Teramura T., Danesino C., et al. Lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene. Blood 97 4 (2001) 1131-1133
16. Imashuku S., Kuriyama K., Sakai R., Nakao Y., Masuda S., Yasuda N., et al. Treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) in young adults: a report from the HLH study center. Med Pediatr Oncol 41 2 (2003) 103-109
17. Stephan J.L., Donadieu J., Le Deist F., Blanche S., Griscelli C., and Fischer A. Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins, steroids and cyclosporin A. Blood 82 (1993) 2319-2323
18. Milone M.C., Tsai D.E., Hodinka R.L., et al. Treatment of primary Epstein- Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy. Blood 105 (2005) 994-996
19. Filipovich A.H., Imashuku S., Henter J.I., and Sullivan K.E. Healing hemophagocytosis. Clin Immunol 117 2 (2005) 121-124
20. Henzan T., Nagafuji K., Tsukamoto H., Miyamoto T., Gondo H., Imashuku S., et al. Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis. Am J Hematol 81 1 (2006) 59-61
21. Chang Y.H., Lee D.S., Jo H.S., Cho S.I., Yoon H.J., Shin S., et al. Tumor necrosis factor alpha promoter polymorphism associated with increased susceptibility to secondary hemophagocytic lymphohistiocytosis in the Korean population. Cytokine 36 1-2 (2006) 45-50
22. Lee J.S., Kang J.H., Lee G.K., and Park H.J. Successful treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-94 protocol. J Korean Med Sci 20 2 (2005) 209-214
23. Fischer A., Cerf-Bensussan N., Blanche S., et al. Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis. J Pediatr 108 (1986) 267-270
24. Yakushijin K., Mizuno I., Sada A., Imoto S., Koizumi T., Imashuku S., et al. Cyclosporin neurotoxicity with Epstein-Barr virus-associated hemophagocytic syndrome. Haematologica 90 3 (2005) ECR11
25. Kasahara Y., Yachie A., Takei K., Kanegane C., Okada K., Ohta K., et al. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood 98 6 (2001) 1882-1888